ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00461773
Recruitment Status : Unknown
Verified June 2009 by Yale University.
Recruitment status was:  Recruiting
First Posted : April 18, 2007
Last Update Posted : June 9, 2009
Sponsor:
Collaborators:
Novartis
Genentech, Inc.
Information provided by:
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2010
  Estimated Study Completion Date : May 2010